149 related articles for article (PubMed ID: 32548687)
1. Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma.
Higaki E; Fukaya M; Miyata K; Kawai R; Abe T
Surg Case Rep; 2020 Jun; 6(1):138. PubMed ID: 32548687
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection of hepatocellular carcinoma after proton beam therapy: A case report.
Kinjo N; Ikeda Y; Taguchi K; Sugimoto R; Maehara S; Tsujita E; Kawano H; Yamaguchi S; Egashira A; Minami K; Yamamoto M; Morita M; Toh Y; Okamura T
Hepatol Res; 2016 Mar; 46(5):483-8. PubMed ID: 26286377
[TBL] [Abstract][Full Text] [Related]
3. Intensity Modulated Proton Therapy with Advanced Planning Techniques in a Challenging Hepatocellular Carcinoma Patient.
Apisarnthanarax S; Saini J; O'Ryan-Blair A; Castro J; Bowen SR
Cureus; 2017 Sep; 9(9):e1674. PubMed ID: 29152431
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
5. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation.
Li Y; Shimizu S; Mizumoto M; Iizumi T; Numajiri H; Makishima H; Li G; Sakurai H
Cureus; 2022 Jun; 14(6):e25744. PubMed ID: 35812555
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study.
Ishida T; Mizumoto M; Saito T; Okumura T; Miura K; Makishima H; Iizumi T; Numajiri H; Baba K; Murakami M; Nakamura M; Nakai K; Sakurai H
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893169
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
[TBL] [Abstract][Full Text] [Related]
8. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
9. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.
Kim TH; Park JW; Kim BH; Kim DY; Moon SH; Kim SS; Lee JH; Woo SM; Koh YH; Lee WJ; Kim CM
Oncotarget; 2018 Jan; 9(3):4034-4043. PubMed ID: 29423102
[TBL] [Abstract][Full Text] [Related]
10. Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature.
Lin YL
World J Hepatol; 2018 Oct; 10(10):772-779. PubMed ID: 30386470
[TBL] [Abstract][Full Text] [Related]
11. Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma.
Su CW; Hou MM; Huang PW; Chou YC; Huang BS; Tseng JH; Hsu CW; Chang TC; Lin SM; Lin CC
Am J Cancer Res; 2022; 12(4):1606-1620. PubMed ID: 35530291
[TBL] [Abstract][Full Text] [Related]
12. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
Liu PH; Huo TI; Miksad RA
Semin Liver Dis; 2018 Aug; 38(3):242-251. PubMed ID: 30041276
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis.
Chen MY; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Tsang NM; Chan KM; Lee WC
Biomed Res Int; 2016; 2016():6017406. PubMed ID: 27999803
[No Abstract] [Full Text] [Related]
15. A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.
Abei M; Okumura T; Fukuda K; Hashimoto T; Araki M; Ishige K; Hyodo I; Kanemoto A; Numajiri H; Mizumoto M; Sakae T; Sakurai H; Zenkoh J; Ariungerel G; Sogo Y; Ito A; Ohno T; Tsuboi K
Radiat Oncol; 2013 Oct; 8():239. PubMed ID: 24131485
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
17. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
Yoo GS; Yu JI; Park HC; Hyun D; Jeong WK; Lim HY; Choi MS; Ha SY
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847035
[TBL] [Abstract][Full Text] [Related]
18. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma.
Kim TH; Park JW; Kim YJ; Kim BH; Woo SM; Moon SH; Kim SS; Koh YH; Lee WJ; Park SJ; Kim JY; Kim DY; Kim CM
Cancer Res Treat; 2015 Jan; 47(1):34-45. PubMed ID: 25381830
[TBL] [Abstract][Full Text] [Related]
19. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
Kim TH; Park JW; Kim BH; Oh ES; Youn SH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY
Front Oncol; 2020; 10():542. PubMed ID: 32411594
[No Abstract] [Full Text] [Related]
20. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein.
Yu SJ; Kim YJ
World J Hepatol; 2015 Jun; 7(11):1553-61. PubMed ID: 26085914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
